R. Balena

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.

R. Balena, Brian C. Toolan, M. Shea et al. · Journal of Clinical Investigation · 1993 · 399 citations · Full text

Aminobisphosphonate Alendronate, Bone Health, Orthopaedic Surgery +14

Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study.

Pierre D. Delmas, R. Balena, E Confravreux et al. · Journal of Clinical Oncology · 1997 · 276 citations

Comparison of the distribution of 3H-alendronate and 3H-Etidronate in rat and mouse bones

P. Masarachia, Miron Weinreb, R. Balena et al. · Bone · 1996 · 248 citations

Mechanobiology, Mouse Bones, Bone Health +12

Piragliatin (RO4389620), a Novel Glucokinase Activator, Lowers Plasma Glucose Both in the Postabsorptive State and after a Glucose Challenge in Patients with Type 2 Diabetes Mellitus: A Mechanistic Study

Riccardo C. Bonadonna, Tim Heise, Christophe Arbet‐Engels et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 140 citations · Full text

Bone resorption and formation on the periosteal envelope of the ilium: A histomorphometric study in healthy women

R. Balena, Mei‐Shu Shih, Alwyn M. Parfitt · Journal of Bone and Mineral Research · 1992 · 120 citations

Bone Disease, Bone Imaging, Longitudinal Growth +15